Phase 2 Proof-of-Concept Study of the Safety and Efficacy of Alfimeprase to Rapidly Open Arteries and Restore Brain Function Following a Stroke
Clinical trial NCT00499902 · TERMINATED
Trial details
- NCT number
- NCT00499902
- Sponsor
- ARCA Biopharma, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-06-01
- Primary completion
- 2008-05-01
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.